Oxybutynin and Ceftazidime drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Oxybutynin (oxybutynin) and Ceftazidime (ceftazidime). Common drug interactions include aplastic anaemia among females and aplastic anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Oxybutynin and Ceftazidime. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Oxybutynin?

Oxybutynin has active ingredients of oxybutynin. It is often used in urge incontinence. eHealthMe is studying from 23,143 Oxybutynin users. Check the latest studies of Oxybutynin.

What is Ceftazidime?

Ceftazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,327 Ceftazidime users. Check the latest studies of Ceftazidime.

On Jul, 14, 2026

17 people who take Oxybutynin and Ceftazidime together, and have interactions are studied.

Oxybutynin and Ceftazidime drug interactions.

What are the common drug interactions of Oxybutynin and Ceftazidime, by gender? *:

female:

Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
Mucosal inflammation (infection of mucous membrane)
Aplasia (defective development or congenital absence of an organ or tissue)
Bacteraemia (presence of bacteria in the blood)
Epistaxis (bleed from the nose)
Epstein-barr virus infection
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Thrombocytopenia (decrease of platelets in blood)
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Drug eruption (adverse drug reaction of the skin)

male:

Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
Adenovirus infection
Cytogenetic abnormality
Drug ineffective
Graft versus host disease in lung (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the lung)
Haemorrhage intracranial (bleeding within the skull)
Hypotension (abnormally low blood pressure)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Peripheral sensory neuropathy (damage to one or more of your peripheral nerves)
Poisoning

What are the common drug interactions of Oxybutynin and Ceftazidime, by age (0-1 to 60+)? *:

0-1:

Cytogenetic abnormality

2-9:

Epistaxis (bleed from the nose)
Adenovirus infection
Lip haemorrhage (bleeding lip)
Mucosal inflammation (infection of mucous membrane)
Respiratory distress (difficulty in breathing)
Stomatitis (inflammation of mucous membrane of mouth)
Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
Aplasia (defective development or congenital absence of an organ or tissue)
Bacteraemia (presence of bacteria in the blood)
Epstein-barr virus infection

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
Haemorrhage intracranial (bleeding within the skull)
Hypotension (abnormally low blood pressure)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Poisoning
Respiratory failure (inadequate gas exchange by the respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)

50-59:

n/a

60+:

Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Peripheral sensory neuropathy (damage to one or more of your peripheral nerves)

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 23.53%
Immunodeficiency Disorders: 2 people, 11.76%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 2 people, 11.76%
Urinary Tract Infection: 1 person, 5.88%
Pyelonephritis Acute (sudden inflammation of kidney caused by bacteria): 1 person, 5.88%
Opsoclonus Myoclonus (a rare neurological disorder of unknown causes which appears to be the result of an autoimmune process involving the nervous system): 1 person, 5.88%
Movement - Uncoordinated: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Oxybutynin and Ceftazidime?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously